NovoCure (NVCR) Other Accumulated Expenses (2014 - 2018)

NovoCure's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $32000.0 for Q4 2018.

• In Q4 2018, Other Accumulated Expenses fell 77.78% year-over-year to $32000.0; the TTM figure through Dec 2018 stood at $32000.0 (down 77.78% YoY), while the FY2018 annual figure was $32000.0, down 77.78% from the prior year.
• Other Accumulated Expenses came in at $32000.0 for Q4 2018 at NovoCure, down from $144000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $712000.0 in Q4 2015 to a low of $32000.0 in Q4 2018.
• A 5-year average of $212200.0 and a median of $97000.0 in 2014 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses surged 634.02% in 2015 and slumped 89.33% in 2016, its largest moves.
• NovoCure's Other Accumulated Expenses stood at $97000.0 in 2014, then soared by 634.02% to $712000.0 in 2015, then plunged by 89.33% to $76000.0 in 2016, then surged by 89.47% to $144000.0 in 2017, then slumped by 77.78% to $32000.0 in 2018.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $32000.0, $144000.0, and $76000.0 for Q4 2018, Q4 2017, and Q4 2016 respectively.

Peer Comparison